Abstract

BackgroundAccording to the Healthcare Cost and Utilization Project (HCUP), mortality in Clostridium difficile infection (CDI) has been rising since 2009, and an upward trend in mortality has been noted. Although there have been studies exploring the incidence of CDI and mortality in the national database, those studies were limited to one particular year. With the advent of newer modalities of diagnosis and treatment for CDI, the recent multiyear trend in disease-specific outcomes from large administrative databases is unknown.ObjectiveTo study the recent trend in nationwide hospital admissions and mortality along with hospital outcomes.MethodsWe queried the identified National Inpatient Sample from 2007 to 2011 to identify patients of age >18 years, with a discharge diagnosis of CDI identified by the International Classification of Diseases, 9th edition (ICD-9), clinical modification codes 008.45, respectively.ResultsWe identified a decline in CDI mortality to 2.67% in 2011 as compared to 3.83% in 2007 (P<0.0001) with CDI as the primary discharge diagnosis and a downward trend in all-cause mortality from 9.2% in 2007 to 7.9% in 2011 (P<0.0001). We identified an upward trend in CDI-related hospital discharges from 2007 (N=325,022) to 2011 (N=333498). Hospital discharges with CDI as a primary discharge diagnosis also increased from 2007 (N=104,123) to 2011 (123,898). The mean length of stay decreased from 7.16 days in 2007 to 6.40 days in 2011 (P 0.0001). CDI was noted to be more common in the elderly (61-80), with a mean age of 68 years. Patients were of Caucasian descent (67%), female (64%), and primarily a Medicare payer (69%). Mean hospital charges increased from $31,551 to 35,654$ (P .04). Of interest, CDI was noted to be more common in large bed-sized non-teaching hospitals (57%) than large bed-sized teaching hospitals (42%). In terms of the geographical distribution of CDI, the southern states of the US had an increased incidence of CDI (36%) and the west coast (16%) had the least incidence.Conclusion Our study shows an improved trend in-hospital mortality outcomes and a decreased length of stay likely related to the advancement in CDI treatments. Hospital charges were increased from 2007 to 2011 in spite of a decrease in hospital length of stay.

Highlights

  • Clostridium difficile (C. difficile) is an anaerobic, gram-positive, spore-forming bacterium that is responsible for most nosocomial diarrhea in hospitalized patients and long-term facilities [1]

  • We identified a decline in Clostridium difficile infection (CDI) mortality to 2.67% in 2011 as compared to 3.83% in 2007 (P

  • We identified an upward trend in CDI-related hospital discharges from 2007 (N=325,022) to 2011 (N=333498)

Read more

Summary

Introduction

Clostridium difficile (C. difficile) is an anaerobic, gram-positive, spore-forming bacterium that is responsible for most nosocomial diarrhea in hospitalized patients and long-term facilities [1]. The Center for Disease Control and Prevention identified Clostridium difficile infection (CDI) and upgraded the level of risk to “urgent threat" in its recent report on antibiotic resistance in the United States [2]. There has been a steady increase in hospital stay and hospital charges due to CDI for a decade, and as noted by the statistical brief by CDC, hospital stay has leveled off [1,6]. According to the Healthcare Cost and Utilization Project (HCUP), mortality in Clostridium difficile infection (CDI) has been rising since 2009, and an upward trend in mortality has been noted. With the advent of newer modalities of diagnosis and treatment for CDI, the recent multiyear trend in disease-specific outcomes from large administrative databases is unknown

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.